[Pharmacological studies of amikacin (BB-K8) (author's transl)].
D000583:Amikacin / Q000008:administration & dosage / Q000494:pharmacology*; D000700:Analgesics; D000779:Anesthetics, Local; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects
D000700:Analgesics; D000779:Anesthetics, Local; D007612:Kanamycin; D000583:Amikacin